West Pharmaceutical Services Inc
WST· NYSE
Released Apr 26, 2018, during market hours
10-Q filed May 8, 2018, 38 days after period end · 0000105770-18-000015
| Metric | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|---|
| Revenue | $415.70M | $387.70M | $362.10M | $335.90M |
| Net Income | $43.60M | $60.90M | $22.10M | $32.90M |
| EPS Diluted |
West Pharmaceutical Services Inc · CIK 105770 · Engraved from SEC EDGAR
| $0.58 |
| $0.81 |
| $0.30 |
| $0.45 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.